Skandinaviska Enskilda Banken Ab (Publ) Moderna, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Moderna, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 66,455 shares of MRNA stock, worth $2.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
66,455
Previous 79,803
16.73%
Holding current value
$2.12 Million
Previous $5.33 Million
48.19%
% of portfolio
0.01%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding MRNA
# of Institutions
903Shares Held
234MCall Options Held
10.6MPut Options Held
18.5M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.28 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.24 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$815 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$537 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$230 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...